Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate/calcium versus heparin/protamine regional anticoagulation for CRRT in acute renal failure
ACTRN12609001079235Phase 4Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, open-label trial of trisodium citrate, calcium, heparin and protamine in acute kidney failure (AKF) (2 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoint: Functional filter life. Started Jan 2010; status: completed.
02
Drugs
trisodium citratecalciumheparinprotamine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12609001079235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609001079235.